ArticleJournal of biometrics & biostatistics2016

Challenges and Innovations in Phase I Dose-Finding Designs for Molecularly Targeted Agents and Cancer Immunotherapies.

Jun Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.